{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "antidepressants",
      "cancer",
      "depression",
      "prescribing",
      "symptoms"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24930693",
  "DateCompleted": {
    "Year": "2016",
    "Month": "01",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2014",
        "Month": "06",
        "Day": "14"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/pon.3606"
    ],
    "Journal": {
      "ISSN": "1099-1611",
      "JournalIssue": {
        "Volume": "24",
        "Issue": "5",
        "PubDate": {
          "Year": "2015",
          "Month": "May"
        }
      },
      "Title": "Psycho-oncology",
      "ISOAbbreviation": "Psychooncology"
    },
    "ArticleTitle": "Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors.",
    "Pagination": {
      "StartPage": "523",
      "EndPage": "532",
      "MedlinePgn": "523-32"
    },
    "Abstract": {
      "AbstractText": [
        "Depressive symptoms and antidepressant use are prevalent among cancer patients. We sought to identify determinants of prescribing commonly used antidepressants.",
        "This multi-institutional study enrolled 3106 ambulatory patients with cancer of the breast, prostate, colon/rectum, or lung. Five case-finding methods were used to identify patients with depressive symptoms. Logistic models were used to examine factors that impact antidepressant use.",
        "Approximately, 47% of patients were defined as having depressive symptoms. Clinicians rated being sad/depressed as one of the top three priority problems for 10.5% of patients. Antidepressants were prescribed in 19% of all patients, 25% with depressive symptoms and 14% nondepressed patients. After adjusting for other covariates, these variable categories were significantly associated with greater use of antidepressants: depressive symptoms, family history of depression, concurrent medication use, cancer treatment status, and certain other clinical and demographic variables. The strongest individual predictors were concurrent use of more than 10 medications (odds ratio [OR]\u2009=\u20093.3), a family history of depression (OR\u2009=\u20092.2), sedative use (OR\u2009=\u20092.1), non-Hispanic white race (OR\u2009=\u20092.0), and anxiolytics use (OR\u2009=\u20092.0).",
        "Depressive symptoms are found in nearly half of outpatients with cancer, and one-fourth of patients with depressive symptoms are taking an antidepressant. Patients receiving antidepressants are more often those taking multiple medications, those with a depression diathesis, and those with more extensive cancer treatment. Patients who were younger, white, and female were also more likely to be taking antidepressants."
      ],
      "CopyrightInformation": "Copyright \u00a9 2014 John Wiley & Sons, Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "The University of Texas MD Anderson Cancer Center, Houston, TX, USA."
          }
        ],
        "LastName": "Fisch",
        "ForeName": "Michael J",
        "Initials": "MJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zhao",
        "ForeName": "Fengmin",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Manola",
        "ForeName": "Judith",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Miller",
        "ForeName": "Andrew H",
        "Initials": "AH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pirl",
        "ForeName": "William F",
        "Initials": "WF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wagner",
        "ForeName": "Lynne I",
        "Initials": "LI"
      }
    ],
    "GrantList": [
      {
        "GrantID": "U10 CA017145",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U10 CA037403",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UG1 CA189828",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Observational Study"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Psychooncology",
    "NlmUniqueID": "9214524",
    "ISSNLinking": "1057-9249"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Anxiety Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Hypnotics and Sedatives"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Anxiety Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [
        "psychology"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [
        "psychology"
      ],
      "DescriptorName": "Colorectal Neoplasms"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Hypnotics and Sedatives"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Logistic Models"
    },
    {
      "QualifierName": [
        "psychology"
      ],
      "DescriptorName": "Lung Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "psychology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Odds Ratio"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Outpatients"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prevalence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prospective Studies"
    },
    {
      "QualifierName": [
        "psychology"
      ],
      "DescriptorName": "Prostatic Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "White People"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ],
  "CoiStatement": "<b>Conflict of interest disclosure:</b> The authors have no conflicts of interest to disclose in association with this study."
}